Articles Tagged With:
-
The NOF Guideline on Prevention and Treatment of Osteoporosis
In persons with low BMD, guidelines suggest vertebral imaging dependent on age and other specific risk factors, such as low-trauma fracture during adulthood, height loss, or long-term steroid use.
-
Treatment of Depression: Sometimes, It’s Hard to Beat Placebo
Clinical trials in major depression may benefit from attending to issues that tend to magnify placebo response.
-
Reflections on the Consequences of Morning BP Surge
Study determined morning BP surge was associated with increase CV risk in Japanese, but not African-American, men.
-
Does Hypovitaminosis D Increase Risk of Atrial Fibrillation in Hypertensive Patients?
Explanations for how vitamin D might be related to AFIB include the observation that activation of the renin-angiotensin-aldosterone system is heightened in vitamin D deficiency states.
-
FDA Actions
The FDA has approved the first spray-dried fibrin sealant to help control bleeding during surgery. -
Treating CDI with Fecal Microbiota Transplantation
Recurrent Clostridium difficile infection (CDI) is defined as the recurrence of infection after successful initial therapy. -
Low Molecular Weight Heparin and RPL
The common practice of giving daily low molecular weight heparin to women to prevent recurrent pregnancy loss may not be an effective intervention, according to a new study.
-
Ramelteon May Be Effective for Treating Delirium
According to the findings of a new study, Ramelteon may be effective for treating delirium in older hospitalized patients. -
Carbon Monoxide Toxicity in the Elderly
Hyperbaric oxygen treatment is generally considered the optimum treatment resource for carbon monoxide toxicity, although a Cochrane review did not confirm the superiority of hyperbaric oxygen over treatment with normobaric oxygen.
-
ED Push - May 2015 Second Issue